Racial differences in nonalcoholic fatty liver disease in the U.S. population

Obesity

Volumn 22, Issue 1, 2014, Pages 292-299

  Schneider, Andrea L C ^a,b   Lazo, Mariana ^a,b   Selvin, Elizabeth ^a,b   Clark, Jeanne M ^a,b,c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; AFRICAN AMERICAN; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HISPANIC; HUMAN; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PREVALENCE; RACE DIFFERENCE; UNITED STATES;

ADIPOSITY; ADULT; AGED; CONTINENTAL POPULATION GROUPS; CROSS-SECTIONAL STUDIES; DIET; FATTY LIVER; FEMALE; HUMANS; LIFE STYLE; LIVER; MALE; MIDDLE AGED; NUTRITION SURVEYS; PREVALENCE; TRANSAMINASES; UNITED STATES; YOUNG ADULT;

EID: 84892370481     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1002/oby.20426     Document Type: Article

References (31)

1. Clark JM, Brancati FL, Diehl AM,. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 2003; 98 (5): 960-967.
2. Ong JP, Younossi ZM,. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis 2007; 11 (1): 1-16, vii.
3. Bambha K, Belt P, Abraham M, Wilson LA, Pabst M, Ferrell L, et al. Ethnicity and nonalcoholic fatty liver disease. Hepatology 2012; 55 (3): 769-780.
4. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004; 40 (6): 1387-1395.
5. Caldwell SH, Harris DM, Patrie JT, Hespenheide EE,. Is NASH underdiagnosed among African Americans? Am J Gastroenterol 2002; 97 (6): 1496-1500.
6. Guerrero R, Vega GL, Grundy SM, Browning JD,. Ethnic differences in hepatic steatosis: an insulin resistance paradox? Hepatology 2009; 49 (3): 791-801. PMCID: 2675577.
7. Lomonaco R, Ortiz-Lopez C, Orsak B, Finch J, Webb A, Bril F, et al. Role of ethnicity in overweight and obese patients with nonalcoholic steatohepatitis. Hepatology 2011; 54 (3): 837-845.
8. Tabibian JH, Lazo M, Durazo FA, Yeh HC, Tong MJ, Clark JM,. Nonalcoholic fatty liver disease across ethno-racial groups: do Asian-American adults represent a new at-risk population? J Gastroenterol Hepatol 2011; 26 (3): 501-509.
9. Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, Manos MM, et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. Hepatology 2005; 41 (2): 372-379.
10. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011; 140 (1): 124-131.
11. Mohanty SR, Troy TN, Huo D, O'Brien BL, Jensen DM, Hart J,. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. J Hepatol 2009; 50 (4): 797-804.
12. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 2008; 40 (12): 1461-1415.
13. Wagenknecht LE, Palmer ND, Bowden DW, Rotter JI, Norris JM, Ziegler J, et al. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study. Liver Int 2011; 31 (3): 412-416.
14. Argo CK, Caldwell SH,. Epidemiology and natural history of non-alcoholic steatohepatitis. Clin Liver Dis 2009; 13 (4): 511-531.
15. Caldwell SH, Ikura Y, Iezzoni JC, Liu Z,. Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)? J Gastroenterol Hepatol 2007; 22 Suppl 1: S11-S19.
16. Zoratti R,. A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin? Eur J Epidemiol 1998; 14 (1): 9-21.
17. Bellentani S, Tiribelli C, Saccoccio G, Sodde M, Fratti N, De Martin C, et al. Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 1994; 20 (6): 1442-1449.
18. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M,. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn J Med 1988; 27 (2): 142-149.
19. Hernaez R, Lazo M, Bonekamp S, Kamel I, Brancati FL, Guallar E, et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis. Hepatology 2011; 54 (3): 1082-1090.
20. Analytical and Reporting Guidelines: The Third National Health and Nutrition Examination Survey, NHANES III (1988-1994). Hyatsville, MD: National Center For Health Statistics, Center for Disease Control and Prevention; 1996. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes3/nh3gui.pdf.
21. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-1994. National Center for Health Statistics, Center for Disease Control and PRevention, editor. Washington, D.C.: Department of Health and Human Services publication; 1994.
22. Kuczmarski RJ,. Bioelectrical impedance analysis measurements as part of a national nutrition survey. Am J Clin Nutr 1996; 64 (3 Suppl): 453S-458S.
23. Chumlea WC, Guo SS, Kuczmarski RJ, Flegal KM, Johnson CL, Heymsfield SB, et al. Body composition estimates from NHANES III bioelectrical impedance data. Int J Obes Relat Metab Disord 2002; 26 (12): 1596-609.
24. Laboratory procedures used for the Third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Bethesda, MD: U.S. Department of Health and Human Services, Center for Disease Control and Prevention, National Center for Environmental Health, National Center for Health Statistics; 1996. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes3/cdrom/nchs/manuals/ labman.pdf.
25. Third National Health and Nutrition Examination Survey: Hepatic Steatosis Ultrasound Images Assessment Procedures Manual. Hyattsville, MD: National Center For Health Statistics, Center for Disease Control and Prevention; 2011. Available from: http://www.cdc.gov/nchs/data/nhanes/nhanes3/Hepatic-Steatosis- Ultrasound-Procedures-Manual.pdf.
26. Mottin CC, Moretto M, Padoin AV, Swarowsky AM, Toneto MG, Glock L, et al. The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obes Surg 2004; 14 (5): 635-657.
27. Sanyal AJ, Brunt EM, Kleiner DE, Kowdley KV, Chalasani N, Lavine JE, et al. Endpoints and clinical trial design for nonalcoholic steatohepatitis. Hepatology 2011; 54 (1): 344-353.
28. Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011; 343: d6891.
29. Stata. Stata Statistical Software: Release 11. College Station, TX: StataCorp; 2009.
30. Reeder SB, Cruite I, Hamilton G, Sirlin CB,. Quantitative Assessment of Liver Fat with Magnetic Resonance Imaging and Spectroscopy. J Magn Reson Imaging 2011; 34 (4):spcone.
31. Stewart SH,. Racial and ethnic differences in alcohol-associated aspartate aminotransferase and gamma-glutamyltransferase elevation. Arch Int Med 2002; 162 (19): 2236-2239.